BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16729482)

  • 21. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin.
    Hrovatin E; Viel E; Lestuzzi C; Tartuferi L; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Vaccher E; Meneguzzo N; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):637-40. PubMed ID: 16858245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine induced cardiotoxicity: a case report and review of literature.
    Tunio MA; Hashmi A; Shoaib M
    Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angina related to 5-Fluorouracil].
    Luján J; García De Burgos F; Jordán A; García M; Reyes F; Espinosa MD
    Rev Esp Cardiol; 2002 Jul; 55(7):764-7. PubMed ID: 12113705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of acute myocardial infarction during 5-fluorouracil infusion.
    Canale ML; Camerini A; Stroppa S; Porta RP; Caravelli P; Mariani M; Balbarini A; Ricci S
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):835-7. PubMed ID: 17060812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.
    Jensen SA; Hasbak P; Mortensen J; Sørensen JB
    J Clin Oncol; 2010 Dec; 28(36):5280-6. PubMed ID: 21079148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-fluorouracil induced cardiotoxicity: review of the literature.
    Sorrentino MF; Kim J; Foderaro AE; Truesdell AG
    Cardiol J; 2012; 19(5):453-8. PubMed ID: 23042307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report.
    McGlinchey PG; Webb ST; Campbell NP
    BMC Cardiovasc Disord; 2001; 1():3. PubMed ID: 11734065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myocardiotoxicity during 5-fluorouracil therapy.
    Misset B; Escudier B; Leclercq B; Rivara D; Rougier P; Nitenberg G
    Intensive Care Med; 1990; 16(3):210-1. PubMed ID: 2351781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic cardiogenic shock associated with infusion of 5-fluorouracil.
    McKendall GR; Shurman A; Anamur M; Most AS
    Am Heart J; 1989 Jul; 118(1):184-6. PubMed ID: 2741789
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of coronary spasm induced by 5-fluorouracil.
    Gorgulu S; Celik S; Tezel T
    Acta Cardiol; 2002 Oct; 57(5):381-3. PubMed ID: 12405579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
    Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
    Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
    Shaib W; Lee V; Saif MW
    In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiotoxicity induced by 5-fluorouracil or capecitabine].
    Jensen SA; Baeksgaard L; Petersen LN; Reiter L; Sørensen JB
    Ugeskr Laeger; 2010 Jan; 172(1):48-51. PubMed ID: 20056096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge.
    Karabay CY; Gecmen C; Aung SM; Guler A; Candan O; Batgerel U; Kalayci A; Kirma C
    Perfusion; 2011 Nov; 26(6):542-5. PubMed ID: 21628340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
    Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
    Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging to differentiate between ischemic and nonischemic cardiomyopathy.
    Bax JJ; Poldermans D; Schuijf JD; Scholte AJ; Elhendy A; van der Wall EE
    Heart Fail Clin; 2006 Apr; 2(2):205-14. PubMed ID: 17386890
    [No Abstract]   [Full Text] [Related]  

  • 39. Necrotizing fasciitis causing severe myocardial dysfunction with ST-segment elevation in a young man.
    El-Menyar A; Shaikh N
    Am J Emerg Med; 2010 Feb; 28(2):260.e3-5. PubMed ID: 20159418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia.
    Nutting C; Folkes A
    Clin Oncol (R Coll Radiol); 1999; 11(1):66. PubMed ID: 10194593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.